Constitutive and B-cell receptor-induced activation of STAT3 are important signaling pathways targeted by bortezomib in leukemic mantle cell lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20663948

Download in:

View as

General Info

PMID
20663948